Correction: GPRC5D as a novel target for the treatment of multiple myeloma: a narrative review
Blood Cancer J
.
2024 Mar 6;14(1):40.
doi: 10.1038/s41408-024-01018-6.
Authors
Paula Rodriguez-Otero
1
,
Niels W C J van de Donk
2
,
Kodandaram Pillarisetti
3
,
Ingrid Cornax
4
,
Deeksha Vishwamitra
3
,
Kathleen Gray
5
,
Brandi Hilder
3
,
Jaszianne Tolbert
3
,
Thomas Renaud
6
,
Tara Masterson
3
,
Christoph Heuck
3
,
Colleen Kane
3
,
Raluca Verona
3
,
Philippe Moreau
7
,
Nizar Bahlis
8
,
Ajai Chari
9
Affiliations
1
Clínica Universidad de Navarra, CCUN, University of Navarra, Pamplona, Spain. paurodriguez@unav.es.
2
Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
3
Janssen Research & Development, Spring House, PA, USA.
4
Janssen Research & Development, La Jolla, CA, USA.
5
Janssen Scientific Affairs, Horsham, PA, USA.
6
Janssen Research & Development, Raritan, NJ, USA.
7
University Hospital Hôtel-Dieu, Nantes, France.
8
Arnie Charbonneau Cancer Research Institute, University of Calgary, Calgary, Alberta, Canada.
9
Icahn School of Medicine at Mount Sinai, New York, NY, USA.
PMID:
38448422
PMCID:
PMC10918080
DOI:
10.1038/s41408-024-01018-6
No abstract available
Publication types
Published Erratum